Protective effect of Asarum polysaccharide on H1N1 influenza virus infection and expression of inflammatory factors.
10.19540/j.cnki.cjcmm.20200929.401
- Author:
Jia YANG
1
;
Ye-Pei FU
1
;
Bao-Xiang DU
1
;
Yong YANG
2
;
Rong RONG
2
Author Information
1. Shandong University of Traditional Chinese Medicine Ji'nan 250355, China.
2. Shandong University of Traditional Chinese Medicine Ji'nan 250355, China Shandong Provincial Collaborative Innovation Center for Antiviral Traditional Chinese Medicine Ji'nan 250355, China.
- Publication Type:Journal Article
- Keywords:
Asarum polysaccharide;
H1N1 influenza virus;
Mahuang Xixin Fuzi Decoction;
cytokines;
kidney Yang deficiency
- MeSH:
Animals;
Antiviral Agents/therapeutic use*;
Asarum;
Cytokines/genetics*;
Drugs, Chinese Herbal;
Influenza A Virus, H1N1 Subtype;
Influenza, Human/genetics*;
Lung;
Mice;
Polysaccharides
- From:
China Journal of Chinese Materia Medica
2021;46(2):412-419
- CountryChina
- Language:Chinese
-
Abstract:
In this paper, Asarum polysaccharides(AP) were extracted, and its composition was analyzed to study the activity against H1 N1 influenza virus in vitro and its intervention effect on mice with kidney Yang deficiency syndrome. AP was prepared by the strategy of water extraction and alcohol precipitation, the content was determined, and its monosaccharide composition was analyzed. The cell Real-time monitoring system and Reed-Muench model were adopted to evaluate the antiviral activity of AP in vitro. And the mouse model of kidney Yang deficiency syndrome was established in vivo to compare the efficacy of Mahuang Xixin Fuzi Decoction(MXF) and AP. MXF group and AP group were treated with clinical equivalent doses of 1.8 g·kg~(-1)·d~(-1) and 0.077 g·kg~(-1)·d~(-1) respectively, once a day for 6 consecutive days. Real-time PCR was used to detect the relative expression of M gene of H1 N1 influenza virus and cytokines in lung tissue. The content of AP in Asarum was 25.22%, and the protein content was 0.8%. And the monosaccharide composition was identified as L-rhamnose, D-arabinose, D-xylose, D-glucose, D-galactose and D-mannose. TI values of Tamiflu, MXF and AP were 30.00, 8.06 and 10.33, respectively. Three different doses of AP could significantly reduce the concentration of virus in supernatant. Compared with the model mice, lung indexes of MXF group and AP group decreased significantly(P<0.05), and the relative expression of M gene decreased significantly(P<0.05). The relative expressions of IL-10 and IFN-γ were up-regulated to varying degrees, while the relative gene expressions of IL-1β, IL-6 and MCP-1 were down-regulated to different degrees. In addition, AP could significantly enhance the expression of TNF-α(P<0.01). AP had a good anti-influenza virus activity in vitro, and could protect mice with kidney Yang deficiency syndrome by reducing the viral load in lung tissue, decreasing inflammation damage in lung tissue, and regulating the expression of inflammatory cytokines. Compared with the prescription of MXF, AP had a better antiviral activity.
